Structural adaptation and heterogeneity of normal and tumor microvascular networks

PLoS Computational Biology

Volumn 5, Issue 5, 2009, Pages

  Pries, Axel R ^a,b   Cornelissen, Annemiek J M ^a,c   Sloot, Anoek A ^d   Hinkeldey, Marlene ^a   Dreher, Matthew R ^e   Höpfner, Michael ^a   Dewhirst, Mark W ^f   Secomb, Timothy W ^g  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c UNIVERSITÉ PARIS DIDEROT   (France)

^d DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BLOOD VESSELS; METABOLISM; MICROCIRCULATION; OXYGEN;

ADAPTIVE RESPONSE; COMPUTATIONAL SIMULATION; FUNCTIONAL HETEROGENEITY; HAEMODYNAMICS; MICROVASCULAR NETWORK; NORMAL TISSUE; PROPERTY; STRUCTURAL ADAPTATION; STRUCTURAL HETEROGENEITY; VASCULAR NETWORK;

TUMORS;

OXYGEN;

ARTICLE; BLOOD FLOW; ERYTHROCYTE; HEMODYNAMICS; MICROCIRCULATION; VASCULAR TUMOR; ADAPTATION; ANIMAL; BIOLOGICAL MODEL; CANCER TRANSPLANTATION; COMPUTER SIMULATION; METABOLISM; MICROVASCULATURE; MOUSE; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; SPLANCHNIC BLOOD FLOW; VASCULARIZATION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; COMPUTER SIMULATION; HEMODYNAMICS; MICE; MICE, NUDE; MICROVESSELS; MODELS, CARDIOVASCULAR; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; SPLANCHNIC CIRCULATION;

EID: 67049155678     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1000394     Document Type: Article

References (58)

1. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186.
2. Jain RK (2001) Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7: 987-989. (Pubitemid 32937367)
3. Gazit Y, Berk DA, Leunig M, Baxter LT, Jain RK (1995) Scale-invariant behavior and vascular network formation in normal and tumor tissue. Phys Rev Lett 75: 2428-2431.
4. Baish JW, Gazit Y, Berk DA, Nozue M, Baxter LT, Jain RK (1996) Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model. Microvasc Res 51: 327-346. (Pubitemid 26162001)
5. Dewhirst MW, Navia IC, Brizel DM, Willett C, Secomb TW (2007) Multiple etiologies of tumor hypoxia require multifaceted solutions. Clin Cancer Res 13: 375-377. (Pubitemid 46225338)
6. Sorg BS, Moeller BJ, Donovan O, Cao Y, Dewhirst MW (2005) Hyperspectral imaging of hemoglobin saturation in tumor microvasculature and tumor hypoxia development. J Biomed Opt 10: 44004. (Pubitemid 43328906)
7. Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307: 58-62. (Pubitemid 40093472)
8. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91. (Pubitemid 26008141)
9. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, Colgan SP (2002) Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62: 3387-3394. (Pubitemid 34651384)
10. Teicher BA (1996) A systems approach to cancer therapy. (Antioncogenics+-standard cytotoxics->mechanism(s) of interaction). Cancer Metastasis Rev 15: 247-272. (Pubitemid 26236124)
11. Ma J, Pulfer S, Li S, Chu J, Reed K, Gallo JM (2001) Pharmacodynamic- mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. Cancer Res 61: 5491-5498. (Pubitemid 32694932)
12. Zhong H, Bowen JP (2006) Antiangiogenesis drug design: multiple pathways targeting tumor vasculature. Curr Med Chem 13: 849-862.
13. Folkman J (1997) Angiogenesis and angiogenesis inhibition: an overview. EXS 79: 1-8.
14. Goede V, Fleckenstein G, Dietrich M, Osmers RG, Kuhn W, Augustin HG (1998) Prognostic value of angiogenesis in mammary tumors. Anticancer Res 18: 2199-2202. (Pubitemid 28386488)
15. Hellmann K (2004) Recognition of tumor blood vessel normalization as a new antiangiogenic concept. Nat Med 10: 329-330. (Pubitemid 38508500)
16. Jain RK, Tong RT, Munn LL (2007) Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Res 67: 2729-2735. (Pubitemid 46548961)
17. Dickson PV, Hamner JB, Sims TL, Fraga CH, Ng CY, Rajasekeran S, Hagedorn NL, McCarville MB, Stewart CF, Davidoff AM (2007) Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy. Clin Cancer Res 13: 3942-3950. (Pubitemid 47037602)
18. Hopfner M, Schuppan D, Scherubl H (2008) Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer. World J Gastroenterol 14: 1-14. (Pubitemid 351314320)
19. Pries AR, Reglin B, Secomb TW (2001) Structural adaptation of microvascular networks: functional roles of adaptive responses. Am J Physiol Heart Circ Physiol 281: H1015-H1025. (Pubitemid 32879235)
20. Chaplain M, Anderson A (2004) Mathematical modelling of tumour-induced angiogenesis: network growth and structure. Cancer Treat Res 117: 51-75.
21. Pamuk S (2006) A mathematical model for capillary formation and development in tumor angiogenesis: a review. Chemotherapy 52: 35-37. (Pubitemid 43004436)
22. Stamper IJ, Byrne HM, Owen MR, Maini PK (2007) Modelling the role of angiogenesis and vasculogenesis in solid tumour growth. Bull Math Biol 69: 2737-2772. (Pubitemid 350029426)
23. Addison-Smith B, McElwain DL, Maini PK (2008) A simple mechanistic model of sprout spacing in tumour-associated angiogenesis. J Theor Biol 250: 1-15. (Pubitemid 350160704)
24. McDougall SR, Anderson AR, Chaplain MA (2006) Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. J Theor Biol 241: 564-589. (Pubitemid 44041121)
25. Zakrzewicz A, Secomb TW, Pries AR (2002) Angioadaptation: keeping the vascular system in shape. News Physiol Sci 17: 197-201.
26. Alarcon T, Owen MR, Byrne HM, Maini PK (2006) Multiscale modelling of tumour growth and therapy: the influence of vessel normalisation on chemotherapy. Computational and Mathematical Methods in Medicine 7: 85-119. (Pubitemid 44593983)
27. Maini PK, Alarcon T, Byrne HM, Owen MR, Murphy J (2007) Structural Adaptation in Normal and Cancerous Vasculature. In: Aletti G, Micheletti A, Morale D, Burger M, eds. Math Everywhere, Deterministic and Stochastic Modelling in Biomedicine, Economics and Industry. Berlin Heidelberg: Springer. pp 165-178.
28. Pries AR, Secomb TW, Gaehtgens P (1998) Structural adaptation and stability of microvascular networks: theory and simulations. Am J Physiol 275: H349-H360. (Pubitemid 28394796)
29. Welter M, Bartha K, Rieger H (2008) Emergent vascular network inhomogeneities and resulting blood flow patterns in a growing tumor. J Theor Biol 250: 257-280. (Pubitemid 350297316)
30. Cardenas-Navia LI, Secomb TW, Dewhirst MW (2007) Effects of fluctuating oxygenation on tirapazamine efficacy: Theoretical predictions. Int J Radiat Oncol Biol Phys 67: 581-586. (Pubitemid 46108335)
31. Kawahara N, Ono M, Taguchi K, Okamoto M, Shimada M, Takenaka K, Hayashi K, Mosher DF, Sugimachi K, Tsuneyoshi M, Kuwano M (1998) Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma. Hepatology 28: 1512-1517. (Pubitemid 28549120)
32. Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29: 15-18.
33. Pries AR, Reglin B, Secomb TW (2005) Remodeling of blood vessels: responses of diameter and wall thickness to hemodynamic and metabolic stimuli. Hypertension 46: 725-731. (Pubitemid 43186745)
34. Pries AR, Secomb TW, Gaehtgens P (1996) Relationship between structural and hemodynamic heterogeneity in microvascular networks. Am J Physiol 270: H545-H553. (Pubitemid 126756261)
35. Cornelissen AJ, Dankelman J, VanBavel E, Spaan JA (2002) Balance between myogenic, flow-dependent, and metabolic flow control in coronary arterial tree: a model study. Am J Physiol Heart Circ Physiol 282: H2224-H2237. (Pubitemid 34663033)
36. Segal SS (1994) Cell-to-cell communication coordinates blood flow control. Hypertension 23: 1113-1120. (Pubitemid 24180876)
37. Segal SS, Jacobs TL (2001) Role for endothelial cell conduction in ascending vasodilatation and exercise hyperaemia in hamster skeletal muscle. J Physiol 536: 937-946. (Pubitemid 33019428)
38. de Wit C, Roos F, Bolz SS, Pohl U (2003) Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion. Physiol Genomics 13: 169-177. (Pubitemid 37129181)
39. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407: 249-257.
40. Jain RK, Booth MF (2003) What brings pericytes to tumor vessels? J Clin Invest 112: 1134-1136.
41. di Tomaso E, Capen D, Haskell A, Hart J, Logie JJ, Jain RK, McDonald DM, Jones R, Munn LL (2005) Mosaic tumor vessels: cellular basis and ultrastructure of focal regions lacking endothelial cell markers. Cancer Res 65: 5740-5749. (Pubitemid 40911177)
42. Segal SS, Duling BR (1986) Flow control among microvessels coordinated by intercellular conduction. Science 234: 868-870. (Pubitemid 17186275)
43. de Wit C, Wolfle SE, Hopfl B (2006) Connexin-dependent communication within the vascular wall: contribution to the control of arteriolar diameter. Adv Cardiol 42: 268-283. (Pubitemid 43805870)
44. Figueroa XF, Isakson BE, Duling BR (2004) Connexins: gaps in our knowledge of vascular function. Physiology (Bethesda) 19: 277-284. (Pubitemid 39472639)
45. Looft-Wilson RC, Payne GW, Segal SS (2004) Connexin expression and conducted vasodilation along arteriolar endothelium in mouse skeletal muscle. J Appl Physiol 97: 1152-1158. (Pubitemid 39121446)
46. Suarez S, Ballmer-Hofer K (2001) VEGF transiently disrupts gap junctional communication in endothelial cells. J Cell Sci 114: 1229-1235. (Pubitemid 32288536)
47. Schmitt S, Evers JF, Duch C, Scholz M, Obermayer K (2004) New methods for the computer-assisted 3-D reconstruction of neurons from confocal image stacks. Neuroimage 23: 1283-1298. (Pubitemid 40260352)
48. Pries AR, Ley K, Gaehtgens P (1986) Generalization of the Fahraeus principle for microvessel networks. Am J Physiol 251: H1324-H1332. (Pubitemid 17211659)
49. Pries AR (1988) A versatile video image analysis system for microcirculatory research. Int J Microcirc Clin Exp 7: 327-345.
50. Pries AR, Secomb TW, Gaehtgens P (1995) Structure and hemodynamics of microvascular networks: heterogeneity and correlations. Am J Physiol 269: H1713-H1722.
51. Pries AR, Secomb TW, Gaehtgens P, Gross JF (1990) Blood flow in microvascular networks. Experiments and simulation. Circ Res 67: 826-834.
52. Pries AR, Ley K, Claassen M, Gaehtgens P (1989) Red cell distribution at microvascular bifurcations. Microvasc Res 38: 81-101. (Pubitemid 19188540)
53. Pries AR, Secomb TW, Gessner T, Sperandio MB, Gross JF, Gaehtgens P (1994) Resistance to blood flow in microvessels in vivo. Circ Res 75: 904-915. (Pubitemid 24323525)
54. Murray CD (1926) The physiological principle of minimum work. I.The vascular system and the cost of blood volume. Proc Natl Acad Sci USA 12: 207-214.
55. Pries AR, Secomb TW, Gaehtgens P (1995) Design principles of vascular beds. Circ Res 77: 1017-1023.
56. Pries AR, Reglin B, Secomb TW (2003) Structural response of microcirculatory networks to changes in demand: information transfer by shear stress. Am J Physiol Heart Circ Physiol 284: H2204-H2212. (Pubitemid 36622433)
57. Nelder JA, Mead R (1965) A Simplex-Method for Function Minimization. Computer Journal 7: 308-313.
58. Pries AR, Schonfeld D, Gaehtgens P, Kiani MF, Cokelet GR (1997) Diameter variability and microvascular flow resistance. Am J Physiol 272: H2716-H2725. (Pubitemid 27300448)